This is a great question because the under-eye area remains one of the most challenging regions to treat in aesthetic medicine. The skin is extremely thin, the anatomy varies significantly from person to person, and even small amounts of swelling or product can become visible. For the foreseeable future, volume restoration will continue to play a major role in under-eye treatment. Hyaluronic acid fillers and fat transfer remain the most established options because many under-eye concerns stem from volume loss, hollowing, or structural changes that occur with aging. That said, I believe the future is moving toward treatments that improve tissue quality rather than simply adding volume. One of the most exciting areas of development involves regenerative aesthetics. These treatments aim to stimulate the body's own collagen, elastin, and tissue repair mechanisms. Biostimulatory products, platelet-rich plasma (PRP), platelet-rich fibrin (PRF), exosomes, and other regenerative technologies are receiving increasing attention because they may improve skin thickness, texture, and overall under-eye quality without creating excessive fullness. Regarding DermaClae and similar regenerative or extracellular matrix-based products, the concept is certainly promising. Theoretically, these products could help improve tissue support and skin quality around the eyes. However, we still need more long-term clinical data before they become standard treatments specifically for the tear trough area. Another trend is the increasing use of imaging technologies, such as ultrasound-guided injections. This allows providers to visualize vessels and filler placement more accurately, potentially improving safety and outcomes in a delicate area where complications have historically been a concern. I also think we will continue to see the development of softer, more tissue-integrated fillers designed specifically for thin-skinned areas. The ideal under-eye filler would provide subtle support without attracting excess water, causing puffiness, or becoming visible through the skin. Perhaps the biggest shift is philosophical rather than technological. Many specialists are moving away from aggressively filling tear troughs and instead treating the midface, cheeks, temples, and surrounding structures to create a more natural improvement under the eyes. Sometimes the best under-eye result comes from treating the face as a whole rather than the under-eye area itself. In my view, fillers and fat transfer are not disappearing anytime soon. However, the future will likely involve a combination of structural support, regenerative medicine, collagen stimulation, and improved imaging technologies rather than relying solely on volume replacement. The goal is becoming less about "filling a hollow" and more about restoring healthy, youthful tissue throughout the entire region.